- 著者
- Dwi Hilda Putri T Mirawati Sudiro Rina Yunita Ungke Anton Jaya Beti Ernawati Dewi Fithriyah Sjatha Eiji Konishi Hak Hotta Pratiwi Sudarmono
- 出版者
- 国立感染症研究所 Japanese Journal of Infectious Diseases 編集委員会
- 雑誌
- Japanese Journal of Infectious Diseases (ISSN:13446304)
- 巻号頁・発行日
- pp.JJID.2014.313, (Released:2015-03-13)
- 参考文献数
- 31
- 被引用文献数
- 2 8
The development of a dengue vaccine is a major priority. Several researchers are using Asian 1 and Asian 2 genotypes as vaccine candidates to develop a vaccine for dengue type 2 virus (DENV-2). However, in this study, we constructed a recombinant plasmid-based prM-E gene from the DENV-2 Cosmopolitan genotype as a dengue DNA vaccine candidate. The protein expression levels of recombinant plasmids in CHO cell lines were analyzed using an enzyme-linked immunosorbent assay, western blotting, and sucrose gradients. After immunizing ddY mice three times, DNA vaccine doses of 25 and 100 µg induced humoral immune responses. There was no difference in the neutralizing antibody titer (focus reduction neutralization test 50%) of mice immunized with 25 and 100 µg DNA vaccine doses. A challenge test using 3 × 105 FFU DENV-2 showed that immunized mice could raise anamnestic neutralizing antibody responses at day 4 and 8 post-challenge. An immunogenicity test with BALB/c mice showed that their antibody neutralization titers were lower than those of ddY mice. In addition, the antibodies produced after immunization and challenge test could also neutralize DENV-2 Asian 2 genotype (NGC strain). Thus, the DENV-2 Cosmopolitan genotype may be a DENV-2 vaccine candidate.